23.10.2017
- In a deal that could lead to the development of five new cancer vaccines, US drugs giant Eli Lilly is investing in German biopharma CureVac. Lilly will make an equity investment of...
02.10.2017
- Does the consolidation in the pharmaceutical industry affect CROs/CMOs, e.g. does it create a necessity for outsourcing partners to consolidate, too? Simon Edwards: It is somewhat...
28.09.2017
- Does the consolidation in the pharmaceutical industry affect CROs/CMOs, e.g. does it create a necessity for outsourcing partners to consolidate, too? Mark Rogers: Between 1993 and...
28.09.2017
- Daniel Mueller: The most obvious effect of consolidation in the pharmaceutical industry is a pronounced shift to those activities within the organization that provide the most...
28.09.2017
- Will the consolidation in the pharmaceutical industry level off at any time soon or is it here to stay and will even intensify? Elliott Berger: With the ever-increasing share of...
28.09.2017
- Drug development/manufacturing projects between pharma companies and CDMOs are based on mutual trust and a focus on success. What do the outsourcing partners have to do in order to...
28.09.2017
- Jane Griffiths: Consolidation in the pharma industry is here to stay: as market competition increases, M&As are one of the fastest ways for companies to obtain critical mass...
28.09.2017
- Will the consolidation in the pharmaceutical industry level off at any time soon or is it here to stay and will even intensify? Marcus Hannakam: We think consolidation will proceed...
